Strong critical acclaim and rapid vote accumulation for standout 2026 releases, particularly A24’s “You Can See Everything,” are the main drivers of trader sentiment. The nearly three-hour Nathan Fielder and Lance Oppenheim documentary on Elizabeth Holmes opened to $15 million domestically in limited release, earned a 9.3 IMDb rating with over 37,000 votes (tying The Shawshank Redemption), and posted record Letterboxd scores alongside 99–100% critic aggregates. These metrics signal potential Top 250 entry if the weighted score holds as viewership grows. IMDb’s list favors films with both elite user ratings and substantial vote totals, making theatrical momentum, word-of-mouth, and streaming availability key swing factors for newer titles. Broader 2026 releases show more modest chart performance so far, underscoring how rare high placement remains. Traders will watch vote thresholds, sustained ratings after wider expansion, and any late reviews or platform deals that could accelerate or stall momentum before year-end.
This market will resolve to "Yes" if the named movie is listed on the IMDb Top 250 Movies list by March 31, 2027, 11:59PM ET. Otherwise, this market will resolve to "No". This market will immediately resolve to "Yes" if the listed movie enters the IMDb Top 250 Movies list. The resolution source for this market will be IMDb (https://www.imdb.com/chart/top/). If the resolution source becomes permanently unavailable, this market will resolve to "No".